Plain-English translation of NCT04576130 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The DanICD study is testing whether a device called an implantable cardioverter defibrillator (ICD) can help prevent future life-threatening heart rhythms in people who have survived a cardiac arrest caused by abnormal heartbeats. You would qualify if you've had a heart attack with blocked arteries (which were opened with surgery or catheterization) and survived a cardiac arrest. The study compares people who receive the ICD device with people who receive standard heart medications alone.
Doctors know that people who survive cardiac arrest from dangerous heart rhythms are at risk for it happening again. This study wants to find out whether implanting this device can give better protection than medication alone, especially in patients whose heart function has improved after their arteries were reopened.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to receive the ICD, doctors will implant the device during your hospital stay or within 4 weeks after you go home. If you are in the standard care group, you will take guideline-recommended heart medications. Both groups will be followed over time to track whether they experience future dangerous heart rhythms or need additional treatment. The study involves about 1,200 people across Denmark.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Denmark